TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · no major macro event
INVA

Innoviva Inc

Healthcare · Biotechnology

21.20$ +1.6% vs. previous close Closing price · As of: Oct 9, 2026

Statements

Balance Sheet

Innoviva Inc (INVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,703 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INVA
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
371 379 392 372 391 367 277 339 278 548 590 642 676 725 788 880 922 1,000 1,088 789 887 926 1,107 1,138 1,328 1,231 1,130 1,118 1,188 1,244 1,268 1,225 1,232 1,301 1,254 1,334 1,429 1,635 1,837 1,703
186 198 214 198 221 200 112 179 121 199 252 318 367 431 467 500 572 342 373 148 237 314 318 400 372 444 296 324 305 344 311 358 401 554 582 652 685 728 773 753
93 118 160 128 138 73 27 87 49 62 65 142 173 278 352 413 479 246 283 43 135 202 217 284 301 291 144 173 180 194 178 217 261 305 319 398 477 551 603 570
149 150 170 136 168 129 56 108 55 115 192 250 297 351 384 417 479 246 283 43 135 202 217 284 301 291 144 173 180 194 178 217 261 412 447 498 533 551 612 579
37 47 44 62 52 71 56 71 65 83 59 68 69 79 82 82 92 94 89 104 101 111 94 112 6.7 64 76 81 68 84 76 94 91 86 78 88 94 35 93 111
-37 -47 -44 -62 -52 -0.8 -1.0 0.0 0.0 -83 0.0 -68 – -79 0.0 0.0 – -94 – -104 0.0 -111 -94 4.0 71 56 50 47 41 41 37 37 34 34 41 49 38 39 39 39
0.4 0.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.1 1.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.2 0.2 3.4 0.2 – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – 5.5 5.5 16 27 28 15 18 18 18 18 18 18 18 18 18 18 18 18
184 181 177 174 170 167 163 160 156 153 149 146 143 139 82 82 92 94 122 104 101 111 105 105 258 253 248 243 237 230 224 217 211 208 202 195 186 182 176 169
738 732 726 669 614 610 489 494 386 389 390 396 392 383 382 387 387 392 392 395 395 400 555 572 686 666 568 563 561 569 564 559 563 610 607 619 419 462 495 469
15 20 20 27 33 35 4.1 6.8 4.3 5.7 3.8 7.5 3.3 5.4 2.8 5.4 3.9 6.1 3.8 5.4 3.1 5.8 109 126 37 135 38 39 36 38 30 28 224 236 235 247 48 50 37 47
3.6 7.8 6.7 15 25 25 485 487 – – 0.3 0.3 – – – – – 25 – 0.1 – 0.1 97 97 96 98 1.3 1.2 1.2 1.2 1.3 1.5 193 194 193 193 8.4 0.4 5.3 0.7
0.5 0.1 2.3 0.3 0.6 0.6 0.1 0.1 0.1 0.0 0.1 1.1 0.0 0.0 0.1 0.2 0.6 0.1 0.0 0.0 0.1 0.0 1.8 4.3 3.8 2.9 5.9 4.6 3.8 6.7 0.9 2.0 4.2 2.1 4.7 5.4 6.2 5.0 6.5 4.0
719 708 702 639 578 574 485 487 381 383 385 387 389 377 379 381 383 386 388 390 392 395 539 443 444 540 445 445 446 446 447 447 256 256 257 257 257 258 258 258
-368 -353 -334 -297 -223 -243 -214 -157 -111 154 188 227 267 313 380 457 486 540 634 330 403 415 387 388 641 566 561 555 627 675 704 666 669 691 647 715 1,010 1,173 1,342 1,233
-1,658 -1,633 -1,616 -1,581 -1,557 -1,499 -1,469 -1,415 -1,367 -1,104 -1,070 -1,032 -992 -946 -881 -804 -776 -722 -628 -539 -466 -456 -403 -402 -137 -205 -170 -169 -87 -25 11 -23 -22 -1.8 -48 15 105 269 456 373
122 120 120 120 120 119 114 113 113 113 113 113 113 113 114 114 114 114 114 101 82 82 94 96 96 70 90 65 86 85 85 63 63 84 63 84 85 85 85 73

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?